Insight Genetics Announces Promotions for Two Team Members
News Aug 21, 2014
Insight Genetics researches, develops and commercializes diagnostic tests that guide physicians in their diagnoses, treatment selections, and resistance monitoring for specific populations of cancer patients. Insight Genetics has recently expanded its R&D team to include 6 new members.
“Kasey and Tyler have been great additions to the Insight Genetics team,” said Christopher Callaghan, President and COO of Insight Genetics. “They have played integral roles in our laboratory operations and contributed significantly to our development of companion diagnostics in cancer. We are pleased to recognize their work and promote them to new roles within our company.”
As Research Scientist, Tyler Nielsen will coordinate projects and manage resources in Insight Genetics’ research laboratory for the development of companion diagnostics. Nielsen brings extensive knowledge and skills in molecular diagnostic procedures, concepts and practices to his scientific team. Prior to this new role, Nielsen was a Research Associate III. He received his M.A. in biomedical science from Des Moines University.
Kasey Lawrence, Senior Technology Specialist, is responsible for organizing and overseeing day-to-day operations of Insight Genetics’ Next Generation Sequencing program. Previously, Lawrence was a Research Associate III. He holds a bachelor of science in biology from Tennessee Tech University.
"Cell Quake Elastography" Maps Elasticity of Cell ComponentsNews
In somewhat the same way that seismologists use the vibrations of planet Earth to characterize its deep structure, scientists have discovered a way to use vibrations within cells to identify their mechanical properties.READ MORE
Tweak to Technique Could Bolster Disease DetectionNews
A team of Stanford researchers has developed a technique that they hope could more precisely detect diseases or disorders such as cancer or a heart attack.READ MORE
Diagnosing Immunity to Ebola With Paper Tests & SmartphonesNews
A promising new approach to detect immunity to Ebola virus infection has been developed by researchers from i-sense in a collaboration between UCL and Imperial College London.READ MORE
Comments | 0 ADD COMMENT
Precision Medicine & Biomarkers Leaders Summit: USA
May 07 - May 08, 2018